Nuclease News and Research

RSS
NIH researchers find that the SARS-CoV-2 Nsp15’s uridine cleavage can evade the immune response

NIH researchers find that the SARS-CoV-2 Nsp15’s uridine cleavage can evade the immune response

SARS-CoV-2 limits type I and type III IFN protein biogenesis

SARS-CoV-2 limits type I and type III IFN protein biogenesis

The potential of CRISPR-based diagnostic assays and treatment approaches against COVID-19

The potential of CRISPR-based diagnostic assays and treatment approaches against COVID-19

New approach to scale up genome editing in tiny worms

New approach to scale up genome editing in tiny worms

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Researchers develop new rapid and highly sensitive SAR-CoV-2 RNA detection test

Researchers develop new rapid and highly sensitive SAR-CoV-2 RNA detection test

Researchers discover previously-unknown function in enzyme critical for cancer growth

Researchers discover previously-unknown function in enzyme critical for cancer growth

CRISPR genomic editing to obtain more productive and nutritive plant varieties

CRISPR genomic editing to obtain more productive and nutritive plant varieties

SARS-CoV-2’s nonstructural proteins dysregulate immune responses, study finds

SARS-CoV-2’s nonstructural proteins dysregulate immune responses, study finds

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Peptide-conjugated morpholino oligomers effectively inhibit SARS-CoV-2 in vero cells

Peptide-conjugated morpholino oligomers effectively inhibit SARS-CoV-2 in vero cells

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Researchers develop new kind of CRISPR screen technology to target RNA

Researchers develop new kind of CRISPR screen technology to target RNA

Gene-editing is more error-prone than thought, new findings suggest

Gene-editing is more error-prone than thought, new findings suggest

Researchers discover how a new immune system works to protect bacteria from phages

Researchers discover how a new immune system works to protect bacteria from phages

Horizon Discovery adds predesigned synthetic single guide RNA to its product range

Horizon Discovery adds predesigned synthetic single guide RNA to its product range

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

CRISPR-Cas9 protein can help increase targeting accuracy in genome editing process

CRISPR-Cas9 protein can help increase targeting accuracy in genome editing process

New CRISPR-Cas9 variant has potential to increase precision during gene therapy

New CRISPR-Cas9 variant has potential to increase precision during gene therapy